StockWatch
·
Commodity Chemicals
Corporate Action28 May 2026, 10:49 pm

LCAL: No Deviation in ₹32.02 Cr Fund Utilization for Q4 FY26

AI Summary

Lords Chloro Alkali Limited (LCAL) has filed a Statement of Deviation for the quarter ended March 31, 2026, confirming no deviation or variation in the utilization of ₹32.02 crore. These funds were raised through the allotment of equity shares upon the conversion of convertible warrants. The company utilized the proceeds as approved by shareholders for capital expenditure, working capital requirements, and general corporate purposes. The statement was reviewed and noted by the Audit Committee on May 28, 2026, affirming compliance with the stated objectives.

Key Highlights

  • LCAL confirmed no deviation in fund utilization for Q4 FY26.
  • ₹32.02 Cr from warrant conversion fully utilized as planned.
  • Funds allocated for capex, working capital, and general corporate needs.
  • Audit Committee reviewed and noted the compliance statement.